A detailed history of Creative Planning transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Creative Planning holds 25,999 shares of FLGT stock, worth $523,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,999
Previous 17,924 45.05%
Holding current value
$523,359
Previous $351,000 60.68%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$19.6 - $25.06 $158,270 - $202,359
8,075 Added 45.05%
25,999 $564,000
Q2 2024

Aug 15, 2024

BUY
$19.09 - $22.57 $122,462 - $144,786
6,415 Added 55.74%
17,924 $351,000
Q1 2024

May 10, 2024

BUY
$21.55 - $29.29 $248,018 - $337,098
11,509 New
11,509 $249,000
Q2 2023

Jul 21, 2023

SELL
$28.52 - $40.7 $29,318 - $41,839
-1,028 Reduced 13.22%
6,749 $249,000
Q1 2023

May 15, 2023

BUY
$29.39 - $36.27 $219,749 - $271,190
7,477 Added 2492.33%
7,777 $242,000
Q4 2022

Feb 10, 2023

BUY
$29.23 - $40.28 $8,769 - $12,084
300 New
300 $8,000
Q1 2022

May 16, 2022

SELL
$49.85 - $96.11 $168,293 - $324,467
-3,376 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$77.3 - $105.0 $34,089 - $46,305
441 Added 15.03%
3,376 $340,000
Q3 2021

Nov 10, 2021

SELL
$74.87 - $110.87 $151,237 - $223,957
-2,020 Reduced 40.77%
2,935 $264,000
Q2 2021

Aug 04, 2021

SELL
$66.8 - $100.45 $2.1 Million - $3.16 Million
-31,411 Reduced 86.37%
4,955 $457,000
Q1 2021

Apr 30, 2021

BUY
$59.3 - $183.85 $1.03 Million - $3.21 Million
17,450 Added 92.25%
36,366 $3.51 Million
Q4 2020

Jan 29, 2021

BUY
$31.01 - $52.1 $586,585 - $985,523
18,916 New
18,916 $986,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.